FILE PHOTO: Picture illustration of vials with Pfizer-BioNTech and AstraZeneca coronavirus disease vaccine labels
Researchers from the University of Oxford published results on Monday from a study yet to be peer-reviewed, where they analysed blood samples from participants who were given doses from AstraZeneca-Oxford or Pfizer-BioNTech in a large study looking into mixing of vaccines.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Two-dose vaccines induce lower antibodies against Omicron, study findsResearchers from the University of Oxford published results on Monday from a study yet to be peer-reviewed, where they analysed blood samples from participants who were given doses from AstraZeneca-Oxford or Pfizer-BioNTech in a large study looking into mixing of vaccines. The results come a day after British Prime Minister Boris Johnson warned that two shots will not be enough to contain Omicron, following findings from the UK health agency last week that boosters significantly restore protection against the variant. The Oxford study said that there was no evidence yet that the lower level of infection-fighting antibodies against Omicron could lead to higher risk of severe disease, hospitalisation or death in those who have got two doses of approved vaccines.
Source: YahooSG - 🏆 3. / 71 Read more »
China's Brii says its COVID-19 antibody cocktail retains activity against OmicronBEIJING: China\u0027s Brii Biosciences said on Sunday (Dec 12) lab studies showed that its COVID-19 antibody cocktail retained activity against the Omicron variant, although one of the antibodies showed a substantial drop in activity when tested alone. Test details for the dual-antibody treatment, which last we
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Omicron spreads faster and weakens jabs: WHOThe Omicron coronavirus variant is more transmissible than the Delta strain and reduces vaccine efficacy but causes less severe symptoms according to early data, the World Health Organization said Sunday.
Source: YahooSG - 🏆 3. / 71 Read more »
Early evidence suggests Omicron spreads faster and weakens COVID-19 vaccine jabs: WHOGENEVA: The Omicron coronavirus variant is more transmissible than the Delta strain and reduces vaccine efficacy but causes less severe symptoms according to early data, the World Health Organization said on Sunday (Dec 12). The Delta variant, first identified in India earlier this year, is responsibl We’ve known that for around a week Means big 💰 for pharma It doesnt weaken the jabs. It evades the immune system better.
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »